Ben-Abraham Technologies To Resume Trading.LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--Sept. 2, 1998--Ben-Abraham Technologies Inc. ("B A Tech" (Alberta Stock Exchange Alberta Stock Exchange See Canadian Venture Exchange (CDNX). : BAI n. 1. a language spoken in the Dali region of Yunnan. Noun 1. Bai - the Tibeto-Burman language spoken in the Dali region of Yunnan Baic )) a U.S. biopharmaceutical company, Wednesday announced its stock will resume trading on the Alberta Stock Exchange today, Wednesday, Sept. 2, 1998. The resumption RESUMPTION. To reassume; to promise again; as, the resumption of payment of specie by the banks is general. It also signifies to take things back; as the government has resumed the possession of all the lands which have not been paid for according to the requisitions of the law, and the of trading is the result of the successful conclusion of a customary reinstatement Reinstatement The restoration of an insurance policy after it has lapsed for nonpayment of premiums. review by the Alberta Stock Exchange. BA Tech is now in compliance with all regulatory requirements Regulatory requirements are part of the process of drug discovery and drug development. Regulatory requirements describe what is necessary for a new drug to be approved for marketing in any particular country. for trading on the Alberta Stock Exchange. Stephen M. Simes, president and chief executive officer, said, "We are excited about the resumption of trading in our stock and look forward to continued progress in our product development, increasing shareholder value and building a successful biopharmaceutical company." In another development, on Aug. 20, 1998, the company filed its second quarter 1998 interim financial statements. These statements reflect a cash balance at June 30, 1998 in excess of $3.9 million compared with $1.8 millionas of Dec. 31, 1997. In addition, current liabilities Current Liabilities Usually appearing on a company's balance sheet, it represents the amount owed for interest, accounts payable, short-term loans, expenses incurred but unpaid, and other debts due within one year. decreased almost $1 million for the same six-month period ended June 30, 1998. All references to dollars are in U.S. dollars. BA Tech is a biopharmaceutical company. It is developing and commercializing a proprietary nanoparticle technology for novel vaccines, vaccine adjuvants and drug delivery systems. The company will grow through developing its core technology and by in-licensing additional late-stage pharmaceutical products to expand its product portfolio. Certain statements in this news release may constitute forward looking statements which are not historical facts, and involve risks and uncertainties that could cause actual results to differ from those expected and projected. Neither the Alberta Stock Exchange nor any regulatory authorities Noun 1. regulatory authority - a governmental agency that regulates businesses in the public interest regulatory agency administrative body, administrative unit - a unit with administrative responsibilities or similar bodies have approved or disapproved the information contained herein.
CONTACT: Stephen M. Simes, 847/793-2434
|
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion